The most powerful and even the only effective weapon we currently have to fight COVID-19 is vaccines. In addition, research continues to gain new information on developing immunity against the virus. A new study says that antibodies that babies receive through breast milk are at a level that can treat patients.
A previous study has shown that coronavirus-specific antibodies are formed in the milk of mothers who have been vaccinated with COVID-19. This time, the researchers revealed that the antibodies passed to babies through breastfeeding are capable of treating COVID-19 patients. This information could update treatments for babies infected with the virus.
Does vaccinated mother mean corona resistant baby?
As it is known, COVID-19 is not very effective in individuals under a certain age. Although the Delta variant has lowered the limit to the 30s, children and infants are not at serious risk. However, if a baby becomes ill due to coronavirus, serious hospital care may be needed. The incidence of such conditions under the age of 1 is around 1 in 10.
Measurements made within the scope of the research in question revealed that women with antibodies continued to produce antibodies for up to 10 months and carried it in their milk.
In the study, the transmission of antibodies against COVID-19 into breast milk of 50 women vaccinated with Pfizer, Moderna or Johnson & Johnson vaccines was investigated. The next vaccine to be observed is AstraZeneca. Presenting the results of the research at the Global Breastfeeding Symposium, New York’s Mount Sinai hospital Dr. Rebecca Powell, “If you continue to breastfeed, you will continue to give the antibodies in your milk,” he said.